Historical record - last NADAC effective date: 5/17/2023
Product Information
ZOLMITRIPTAN 2.5 MG ODT is a generic product labeled by Jubilant Cadista Pharmaceuticals Inc., priced at $2.6047 per EA under NDC 59746046116. Its NADAC has been published 287 times since Jul 5, 2017.
FDA first approved this application on Sep 17, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2.5 mg/1
Manufacturer
Jubilant Cadista Pharmaceuticals Inc.NDC
59746046116
Classification
Generic
Dosage Form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Effective Date
5/17/2023
Active Ingredients
ZOLMITRIPTANApproval Type
Generic (ANDA)
FDA Application
ANDA202956FDA Approved
9/17/2015
TE Code
AB
On Market Since
9/17/2015
Pharmacological Classes
Price Statistics
The NADAC for ZOLMITRIPTAN 2.5 MG ODT has been published 287 times since Jul 5, 2017, and over the history we have for it it has declined 62.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.6047 per EA |
|---|---|
| All-time high | $8.0660 (Aug 16, 2017) |
| All-time low | $2.2653 (Mar 22, 2023) |
| Median price | $3.8053 |
| Average price | $4.2220 |
| Largest weekly change | +88.4% (Jul 20, 2022) |
| Weeks tracked | 287 |
| Tracking since | Jul 5, 2017 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
-5.2%
All
-62.1%
Last surveyed May 24, 2023 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 61% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ZOLMITRIPTAN 2.5 MG ODT?
The current National Average Drug Acquisition Cost (NADAC) for ZOLMITRIPTAN 2.5 MG ODT, manufactured by Jubilant Cadista Pharmaceuticals Inc., is $2.6047 per EA (NDC 59746046116), effective May 24, 2023.
How has the price of ZOLMITRIPTAN 2.5 MG ODT changed over time?
Over the history we have for it, the NADAC for ZOLMITRIPTAN 2.5 MG ODT has declined 62.1%. It has been tracked across 287 weekly CMS publications since Jul 5, 2017.
What are the highest and lowest recorded NADAC prices for ZOLMITRIPTAN 2.5 MG ODT?
Since Jul 5, 2017, the NADAC for ZOLMITRIPTAN 2.5 MG ODT has ranged from a low of $2.2653 (Mar 22, 2023) to a high of $8.0660 (Aug 16, 2017), with a median of $3.8053 per EA.
Are there cheaper alternatives to ZOLMITRIPTAN 2.5 MG ODT?
Yes. 9 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ZOLMITRIPTAN 2.5 MG TABLET, is $1.0103 per EA — about 61% below ZOLMITRIPTAN 2.5 MG ODT.
Who manufactures ZOLMITRIPTAN 2.5 MG ODT?
ZOLMITRIPTAN 2.5 MG ODT (NDC 59746046116) is labeled by Jubilant Cadista Pharmaceuticals Inc., and CMS classifies it as a generic product.